Clinical

Dataset Information

0

An investigation of the efficacy of an eHealth nutrition intervention on lifestyle-related colorectal cancer risk in patients undergoing colonoscopy.


ABSTRACT: Interventions: This is a pilot 3-arm randomised controlled trial with the primary aim of investigating the efficacy of an enhanced eHealth nutrition intervention at reducing lifestyle-related colorectal cancer risk (as determined by the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score) at 3 months, within patients undergoing colonoscopy. This will be compared with the efficacy of a standard eHealth nutrition intervention, and no intervention, at reducing lifestyle-related colorectal cancer risk at 3 months, within patients undergoing colonoscopy. Enhanced intervention group: Enhanced group participants will receive one 30 minute online consultation via Zoom with an Accredited Practising Dietitian, and a personal nutrition report generated through completion of the online Australian Eating Survey (AES), at baseline. The one-on-one online consultation with the dietitian, using a standardised format and informed by results of the AES nutrition report, will provide participants with personalised dietary advice, strategies, and resources to improve dietary intake over 3 months, in line with the 2018 WCRF/AICR Recommendations for Cancer Prevention. The personal nutrition report will contain specific information and feedback about the participants’ current dietary intake, including energy intake from core and non-core foods and drinks, macronutrient and micronutrient intake, and diet quality. The resources provided will include resources designed specifically for this study by a team of dietitians, as well as resources readily available from organisations such as the World Cancer Research Fund, Australian Government, Cancer Council, Cancer Institute NSW, and Nutrition Australia. Standard intervention group: Standard group participants w Primary outcome(s): The primary outcome is change in colorectal cancer risk measured using the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score [Baseline, 3 months after randomisation ] Study Design: Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy

DISEASE(S): Colorectal Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)

PROVIDER: 2471933 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-08-26 | BIOMD0000001037 | BioModels
2010-05-26 | E-GEOD-10306 | biostudies-arrayexpress
2021-08-26 | BIOMD0000001038 | BioModels
| 2329183 | ecrin-mdr-crc
2008-03-01 | GSE10306 | GEO
2019-08-08 | GSE135541 | GEO
2013-04-09 | GSE45878 | GEO
2013-04-09 | E-GEOD-45878 | biostudies-arrayexpress
2011-06-01 | E-GEOD-27140 | biostudies-arrayexpress
2012-05-31 | E-GEOD-34436 | biostudies-arrayexpress